Cypherpunk Technologies Receives Nasdaq Delisting Deficiency Notice for Sub-$1.00 Bid Price
CYPH has more than doubled off its 52-week low of $0.222.
Summary
Cypherpunk Technologies Inc. received a Nasdaq deficiency notice for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day period to regain compliance and avoid potential delisting.
Key Events · Legal and Risk Events · CYPH
-
Nasdaq Deficiency Notice Received
On March 4, 2026, Cypherpunk Technologies Inc. received a notification from Nasdaq for non-compliance with the minimum $1.00 closing bid price rule (Rule 5550(a)(2)).
-
Reason for Deficiency
The company's common stock closing bid price has been below $1.00 per share for 30 consecutive business days.
-
Compliance Period
The company has 180 calendar days, until August 31, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.
-
Potential Extension and Strategy
An additional 180-day compliance period may be granted if other listing requirements are met. The company intends to monitor its stock price and consider options, including a reverse stock split, but offers no assurance of regaining compliance.
Analysis · CYPH · Life Sciences
Cypherpunk Technologies Inc. has received a formal notification from Nasdaq regarding its failure to maintain the minimum $1.00 bid price requirement. This deficiency notice is a critical event as it signals a potential threat to the company's continued listing on the Nasdaq Capital Market. While the company has 180 days to regain compliance, failure to do so could lead to delisting, significantly impacting liquidity and investor confidence. Investors should monitor the company's stock price performance and any strategic actions, such as a potential reverse stock split, that the company may undertake to cure the deficiency.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CYPH was trading at $0.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.7M. The 52-week trading range was $0.22 to $3.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.